Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rao, B. M.
Right arrow Articles by Wittrup, K.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, B. M.
Right arrow Articles by Wittrup, K.D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Protein Engineering vol. 16 no. 12 pp. 1081-1087, 2003
© 2003 Oxford University Press

Interleukin-2 mutants with enhanced {alpha}-receptor subunit binding affinity

Balaji M. Rao1, Andrew T. Girvin1, Thomas Ciardelli2, Douglas A. Lauffenburger1 and K.Dane Wittrup1,3

1Department of Chemical Engineering and Biological Engineering Division, Massachusetts Institute of Technology, MIT 66-552, Cambridge, MA 02139 and 2Dartmouth Medical School, Hanover, NH 03755, USA

3 To whom correspondence should be addressed. e-mail: wittrup{at}mit.edu

Stimulation of T-cells by IL-2 has been exploited for treatment of metastatic renal carcinoma and melanoma. However, a narrow therapeutic window delimited by negligible stimulation of T-cells at low picomolar concentrations and undesirable stimulation of NK cells at nanomolar concentrations hampers IL-2-based therapies. We hypothesized that increasing the affinity of IL-2 for IL-2R{alpha} may create a class of IL-2 mutants with increased biological potency as compared with wild-type IL-2. Towards this end, we have screened libraries of mutated IL-2 displayed on the surface of yeast and isolated mutants with a 15–30-fold improved affinity for the IL-2R{alpha} subunit. These mutants do not exhibit appreciably altered bioactivity at 0.5–5 pM in steady-state bioassays, concentrations well below the IL-2R{alpha} equilibrium binding constant for both the mutant and wild-type IL-2. A mutant was serendipitously identified that exhibited somewhat improved potency, perhaps via altered endocytic trafficking mechanisms described previously.

Received June 13, 2003; revised July 30, 2003; accepted September 26, 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. D. Thanos, W. L. DeLano, and J. A. Wells
Hot-spot mimicry of a cytokine receptor by a small molecule
PNAS, October 17, 2006; 103(42): 15422 - 15427.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. W. Colby, Y. Chu, J. P. Cassady, M. Duennwald, H. Zazulak, J. M. Webster, A. Messer, S. Lindquist, V. M. Ingram, and K. D. Wittrup
Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody
PNAS, December 21, 2004; 101(51): 17616 - 17621.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. M. Rao, I. Driver, D. A. Lauffenburger, and K. D. Wittrup
Interleukin 2 (IL-2) Variants Engineered for Increased IL-2 Receptor {alpha}-Subunit Affinity Exhibit Increased Potency Arising from a Cell Surface Ligand Reservoir Effect
Mol. Pharmacol., October 1, 2004; 66(4): 864 - 869.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.